Accessibility Menu
Cue Health logo

Cue Health(OTC) HLTHQ

Market Cap$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-100%
5 YearN/A
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Cue Health last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-24
Cue Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-17
1 month+0%USD 0.002026-06-23
3 month+0%USD 0.002026-04-24
Year to date+0%USD 0.002025-12-31
1 year+0%USD 0.002025-07-24
3 year-100%USD 0.442023-07-25
Since inception-100%USD 20.002021-09-24

Cue Health Financials at a Glance

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$56.23M

Net Income (TTM)

-$328.78M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

2

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 13, 2026

HLTHQ News

Coronavirus

Why Cue Health Blasted Higher Today

Eric VolkmanDec 27, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cue Health

Cue Health Inc. is a healthcare technology firm focused on developing advanced diagnostic platforms. The company provides a range of diagnostic tests for individuals, enterprises, healthcare providers, and public health agencies, utilizing its innovative Cue Integrated Care platform.

Products and Services
  • Comprehensive Cue Integrated Care platform for diagnostics
  • Portable Cue Reader and single-use Cue Cartridges
  • Specialized COVID-19 testing kits
Growth Outlook
  • Revenue increased to $10.05 million in Q1 2024
  • Strong demand for diagnostic solutions amid ongoing health challenges
  • Investment in R&D to enhance product offerings and market reach
Financial Highlights
  • Net income of -$49.52 million in Q1 2024
  • Cash and cash equivalents of $41.02 million as of March 31, 2024
  • Current ratio of 2.54 indicates strong liquidity position
Cue Health Inc. has established itself as a key player in the healthcare technology sector, particularly in diagnostics. The company's innovative products, such as the Cue Integrated Care platform, are designed to meet the growing demand for efficient and accurate diagnostic solutions. Recent financial data indicates a revenue increase, reflecting the company's ability to adapt to market needs. Despite reporting a net loss, the liquidity position remains strong, providing a foundation for future growth. The focus on research and development is expected to drive further advancements in product offerings, positioning Cue Health for potential expansion in the healthcare market.
AI Generated • Jul 4, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

726

CEO

Ayub Khattak

Website

www.cuehealth.com

Headquarters

San Diego, CA 92121, US

HLTHQ Financials

Key Financial Metrics (TTM)

Gross Margin

-97.89%

Operating Margin

-614.82%

Net Income Margin

-581.51%

Return on Equity

-90.35%

Return on Capital

-132.42%

Return on Assets

-109.91%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

159.09M

Volume

2

Avg. Volume

3.81K

Financials (TTM)

Gross Profit

-$47.36M

Operating Income

-$231.84M

EBITDA

-$276.85M

Operating Cash Flow

-$137.81M

Capital Expenditure

-$19.80M

Free Cash Flow

-$157.61M

Cash & ST Invst.

$41.02M

Total Debt

$44.30M

Cue Health Performance Analysis

Cue Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 618,107,000N/A
20222022-12-31USD 483,476,000-21.8%
20232023-12-31USD 70,936,000-85.3%
Cue Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-06-30-60.0%
Q32023-09-3076.6%
Q42023-12-317.6%
Q12024-03-31-46.5%
Cue Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.23N/A
20222022-12-31USD -1.31N/A
20232023-12-31USD -2.4486.3%
Cue Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-06-3011.3%
Q32023-09-3043.6%
Q42023-12-31-209.7%
Q12024-03-3167.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2024YOY CHG

Revenue

$10.05M

-59.4%

Gross Profit

-$6.26M

+58.4%

Gross Margin

-62.29%

N/A

Market Cap

$200.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$0.28

N/A

Employees

726

N/A

Net Income

-$49.52M

+47.4%

EBITDA

-$49.37M

+37.9%

Quarterly Fundamentals

Name
Q1 2024YOY CHG

Total Cash

$41.02M

-77.1%

Total Debt

$44.30M

-16.6%

Accounts Receivable

$389.00K

-96.0%

Inventory

$13.66M

-83.3%

Long Term Debt

$38.32M

-11.4%

Short Term Debt

$5.98M

-39.5%

Return on Assets

-1.10%

N/A

Return on Invested Capital

-1.33%

N/A

Free Cash Flow

-$30.56M

+50.5%

Operating Cash Flow

-$28.72M

+44.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HTGMQHTG Molecular Diagnostics, Inc.
$0.00+0.00%
CLVRClever Leaves Holdings Inc.
$0.00+0.00%
MDVLQMedAvail Holdings, Inc.
$0.00+0.00%
PARDPoniard Pharmaceuticals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About HLTHQ

What is the current price of Cue Health?

Cue Health is trading at $0.00 per share.

What is the 52-week range for Cue Health?

Over the past 52 weeks, Cue Health has traded between $0.00 and $0.00.

How much debt does Cue Health have?

As of the most recent reporting period, Cue Health reported total debt of $47.94M.

How much cash does Cue Health have on hand?

Cue Health reported $81.69M in cash and cash equivalents in its most recent financial results.

What is Cue Health’s dividend yield?

Cue Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services